That same body of work fed into an early-phase human trial registration (NCT02637284) that was later withdrawn before results were reported, which is why anyone telling you BPC-157 is "clinically proven" in humans is overstating the record
John E Deanfield, MD Expanding focus for cardiologists The diabetic patient and cardiovascular outcomesPanel discussion: Expanding focus for cardiologists - The diabetic patient and cardiovascular outcomes Prof
For those who used an alternative as-treated definition for drug use, the analysis found a median follow-up time of 1.8 years with 90-day gap and tail periods (HR, 1.37
If the blood is visibly haemolysed (lots of burst blood cells) the lab will not do the B12 test for that reason
Chaves E, Jeffrey DT, Williams DR
But, if you do take them again, mine as well hedge your bets with a better chance of some utility from them with potentially better forms metabolized